Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.

about

Overview of Ocular Anti-Vascular Endothelial Growth Factor Therapy in the Management of Diabetic Eye Complications.

Item

http://www.wikidata.org/entity/Q36585191

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@ast

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@en

type

Item

label

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@ast

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@en

prefLabel

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@ast

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@en

P1476

Overview of Ocular Anti-Vascul ...... of Diabetic Eye Complications.

@en

P2093

Christine Tran

http://www.w3.org/2001/XMLSchema#string

Oluwaranti Akiyode

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)

Fenofibrate - a potential systemic treatment for diabetic retinopathy?

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

Effects of medical therapies on retinopathy progression in type 2 diabetes

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies.

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

P304

44-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIASPECT.29.1.44

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295098642

http://www.w3.org/2001/XMLSchema#string

P698

26912965

http://www.w3.org/2001/XMLSchema#string

P932

4755448

http://www.w3.org/2001/XMLSchema#string